Analysts Set Expectations for Organigram FY2027 Earnings

Organigram Holdings Inc. (NASDAQ:OGI) – Equities research analysts at Atb Cap Markets issued their FY2027 earnings per share (EPS) estimates for Organigram in a note issued to investors on Tuesday, February 11th. Atb Cap Markets analyst F. Gomes anticipates that the company will earn $0.06 per share for the year. The consensus estimate for Organigram’s current full-year earnings is ($0.09) per share. Atb Cap Markets also issued estimates for Organigram’s FY2028 earnings at $0.14 EPS.

Organigram Trading Up 0.4 %

Shares of NASDAQ OGI opened at $1.36 on Thursday. The business has a 50-day moving average price of $1.56 and a two-hundred day moving average price of $1.67. The firm has a market capitalization of $170.95 million, a PE ratio of -3.54 and a beta of 1.00. Organigram has a one year low of $1.29 and a one year high of $2.91.

Organigram (NASDAQ:OGI) last announced its earnings results on Tuesday, February 11th. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Organigram had a negative net margin of 28.58% and a negative return on equity of 11.68%.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Toronto Dominion Bank increased its holdings in Organigram by 803.7% in the third quarter. Toronto Dominion Bank now owns 16,727 shares of the company’s stock worth $30,000 after buying an additional 14,876 shares during the last quarter. Clear Harbor Asset Management LLC increased its stake in shares of Organigram by 37.4% during the 4th quarter. Clear Harbor Asset Management LLC now owns 45,000 shares of the company’s stock worth $72,000 after purchasing an additional 12,250 shares during the last quarter. Arrowstreet Capital Limited Partnership bought a new position in shares of Organigram during the 4th quarter valued at $1,153,000. Finally, Tidal Investments LLC lifted its stake in shares of Organigram by 8.3% in the 3rd quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock valued at $3,526,000 after purchasing an additional 149,171 shares during the last quarter. Institutional investors and hedge funds own 34.63% of the company’s stock.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.